share_log

Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know

Benzinga ·  Jan 10 12:01

In the latest quarter, 7 analysts provided ratings for IDEAYA Biosciences (NASDAQ:IDYA), showcasing a mix of bullish and bearish perspectives.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings16000
Last 30D01000
1M Ago00000
2M Ago03000
3M Ago12000

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $40.86, a high estimate of $44.00, and a low estimate of $36.00. Surpassing the previous average price target of $37.75, the current average has increased by 8.24%.

price target chart

Decoding Analyst Ratings: A Detailed Look

An in-depth analysis of recent analyst actions unveils how...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment